Functional and hyperfunctional siRNA directed against Bcl-2
US7820809B2 · kind B2 · utility
63Cited by
10References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2005 |
| Grant date | Oct 26, 2010 |
| Priority date | — |
| Expiry date | Mar 18, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/11
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.